Mosaic gp140 vaccine

Mosaic gp140 envelope glycoprotein vaccine · Janssen Vaccines & Prevention B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mosaic gp140 vaccine, covering 2024-07-31 to 2024-07-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals [Phase 3]

See pricing